The Ciba-Geigy Foundation for Cooperation with Developing Countries was established 1979. Its initial charter was “to promote the development of the poorest countries and regions of the Third World, in particular through cooperation in the fields of agriculture, healthcare and education, furthermore, in terms of support to self-help, to provide aid in these countries.”
The foundation became the Novartis Foundation for Sustainable Development after the merger with Sandoz and eventually became solely focused on healthcare.
In 2014, the foundation became the Novartis Foundation to reflect its role as the primary foundation for Novartis, and underlining its increasing focus on supporting projects that drive quality healthcare in low- and middle-income countries, building on the Novartis mission to discover new ways to improve and extend people's lives.
The Novartis Foundation is a non-profit organization pioneering innovative healthcare models that have a transformational impact on the health of the poorest populations. They work hand-in-hand with our local and global partners to catalyze scalable and sustainable healthcare models that improve access and health outcomes, and accelerate efforts to eliminate leprosy and malaria by focusing on interventions that aim to interrupt transmission. Everything they do is grounded in evidence and innovation, and the work is a continuous cycle of evaluation, adaptation and application. In 2016, the operational budget for the foundation was CHF 15 million and our programs reached 8.9 million people.
Geographic focus
Latin America, Sub-Saharan Africa, Southeast Asia
Programme areas
Non communicable diseases (focus on hypertension) and disease elimination (focus on malaria and leprosy)